Cargando…
Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative Colitis
Primary sclerosing cholangitis (PSC), a rare progressive liver disease characterized by cholestasis and bile duct fibrosis, has no accepted, effective therapy known to delay or arrest its progression. We report a 15 year old female patient diagnosed with PSC and moderate chronic active ulcerative co...
Autores principales: | Buness, Cynthia, Lindor, Keith D., Miloh, Tamir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061664/ https://www.ncbi.nlm.nih.gov/pubmed/27738604 http://dx.doi.org/10.5223/pghn.2016.19.3.210 |
Ejemplares similares
-
Microbiome Responses to Vancomycin Treatment in a Child With Primary Sclerosing Cholangitis and Ulcerative Colitis
por: Britto, Savini Lanka, et al.
Publicado: (2021) -
How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
por: Shah, Ayesha, et al.
Publicado: (2022) -
Primary sclerosing cholangitis associated with severe ulcerative colitis in a young man
por: Xavier, José Cândido Caldeira, et al.
Publicado: (2013) -
Oral vancomycin in the treatment of primary sclerosing cholangitis-associated pouchitis
por: Shen, Bo
Publicado: (2021) -
Rapid Progression of Primary Sclerosing Cholangitis Complicated with Ulcerative Colitis
por: Pardak, Piotr, et al.
Publicado: (2015)